Initiate risperidone 2 mg twice daily as a standing order to address psychotic symptoms comprehensively, as the severity of hallucinations and delusions warrants immediate scheduled antipsychotic therapy

Plan to titrate based on response over the first 72 hours and assess for medication continuation at discharge. Obtain baseline metabolic labs and prolactin level prior to initiating treatment. Initiating scheduled antipsychotic therapy at this stage is premature because substance-induced psychosis from methamphetamine typically resolves within days to 1-2 weeks of abstinence. Starting standing risperidone commits the patient to a medication that may not be needed once the stimulant clears. Additionally, risperidone can lower the seizure threshold and cause QTc prolongation in a patient who is already tachycardic and hypertensive from stimulant use. A more conservative approach with as-needed medications for acute agitation is appropriate initially.

Administer lorazepam 2 mg IM for acute agitation and initiate standing olanzapine 10 mg daily

As the combination of benzodiazepine and antipsychotic provides the most rapid and comprehensive symptom control for stimulant-induced psychosis. Plan to reassess the need for antipsychotic continuation after 48 hours of abstinence and taper the benzodiazepine as vital signs normalize. Monitor cardiac rhythm given the sympathomimetic effects of methamphetamine. While the benzodiazepine component is appropriate for acute management of stimulant-related agitation and sympathomimetic symptoms, initiating standing olanzapine at 10 mg daily is unnecessarily aggressive for substance-induced psychosis, which is expected to resolve with abstinence. Olanzapine also carries metabolic risks and anticholinergic effects that complicate monitoring in an acutely intoxicated patient.

Initiate chlorpromazine 50 mg IM to address both agitation and psychosis simultaneously, as its potent sedating properties and broad receptor antagonism are ideal for acute stimulant psychosis management

Plan to transition to oral chlorpromazine 100 mg three times daily once the patient can tolerate oral medications. Monitor closely for orthostatic hypotension, QTc prolongation, and seizure threshold lowering during the acute phase. Chlorpromazine is poorly suited for methamphetamine-induced psychosis because its strong alpha-1 adrenergic blockade can cause severe hypotension in a patient with stimulant-induced cardiovascular instability. Its anticholinergic effects can worsen hyperthermia and tachycardia, and it significantly lowers the seizure threshold. Low-potency typical antipsychotics are generally avoided in acute stimulant intoxication due to these cardiovascular and autonomic risks.

Prioritize benzodiazepines such as lorazepam 1-2 mg IM/IV every 4-6 hours as needed for agitation and sympathomimetic symptoms

With haloperidol 2-5 mg IM available as a PRN for persistent psychotic symptoms not responsive to benzodiazepines alone. Plan to reassess the psychotic symptoms daily during abstinence and avoid initiating any scheduled antipsychotic unless symptoms persist beyond 7-10 days. Monitor vital signs hourly during the acute phase. This approach correctly prioritizes benzodiazepines for managing stimulant-induced agitation and sympathomimetic toxicity, which addresses the most acute safety concerns. PRN haloperidol is appropriate for persistent psychotic symptoms not controlled by benzodiazepines alone.